Fertility warning
This medicine may affect fertility.
Leaflet VANTAS 50mg implant
- Product code:
- W58114001
- Quantity:
- 1
- Indicated for:
- central precocious puberty; prostate cancer
- Route of administration:
- implantation
- Substance:
- histreline (antineoplastic agent)
- ATC
- H01CA03 — Systemic hormonal preparations, excluding sex hormones and insulins | Hypothalamic hormones | Gonadotropin-releasing hormones
Precautions:
Dose adjustment in hepatic impairment
Dose adjustment may be needed in liver disease.
Cytotoxic / special handling
Handle with special care.
Contraception required
Effective contraception is required during treatment.
Contraindicated during breastfeeding
Do not use this medicine while breastfeeding.
Contraindicated during pregnancy
Do not use this medicine during pregnancy.
Hepatotoxicity
This medicine may affect the liver.
Major drug interactions
This medicine may have important interactions with other medicines.
Myelosuppression / agranulocytosis
This medicine may lower blood cell counts.
Additional monitoring
This medicine is subject to additional monitoring.
Requires periodic laboratory tests
Periodic laboratory tests may be required during treatment.
Severe skin reactions
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
Histrelin is a gonadotropin-releasing hormone (GnRH) agonist used for the treatment of advanced prostate cancer and precocious puberty. It works by reducing the production of testosterone or estrogen, thereby suppressing the growth of hormone-sensitive tumors.
The medication is administered as a subcutaneous implant, as directed by a doctor. The implant gradually releases the drug over several months.
Side effects may include hot flashes, headache, decreased libido, or reactions at the implantation site. In rare cases, severe allergic reactions may occur.
Histrelin is not recommended for patients with hypersensitivity to this medication or pregnant women.
The medication is administered as a subcutaneous implant, as directed by a doctor. The implant gradually releases the drug over several months.
Side effects may include hot flashes, headache, decreased libido, or reactions at the implantation site. In rare cases, severe allergic reactions may occur.
Histrelin is not recommended for patients with hypersensitivity to this medication or pregnant women.
General data about VANTAS 50mg
- Substance:
- histreline
- Date of latest medicines list:
- 01-04-2014
- Product code:
- W58114001
- Concentration:
- 50mg
- Pharmaceutical form:
- implant
- Quantity:
- 1
- Product type:
- Original
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.